Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Outcome Of Board Meeting Held On 17Th May 2021.

 The Board of Directors of the Company at their meeting held from 06:00 pm to 09:15 pm today, inter alia, took the following decisions: i. Took on record and duly approved the Audited Financial Results of the Company for the quarter and year ended 31st March 2021 which is enclosed herewith along with the Auditors' Report on the Financial Statements of the Company for the Financial Year ended 31st March 2021 as Annexure 1. In terms of second proviso to regulation 33(3)(d) of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, a declaration by CFO confirming that the Auditors have given an Unmodified Opinion on the Annual Audited Financial Results of the Company for the financial year ended 31st March 2021 is also enclosed as Annexure 2. ii. Accepted the resignation of Mr. Debashis Dey as the Company Secretary and Compliance Officer of the Company after the end of working hours on Friday, 25th June 2021. This is for your information and record.
17-05-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Corrigendum To Outcome Of Board Meeting

 Please refer to our earlier letter no. SPARC/Sec/SE/2021-22/13 dated 12th May 2021 on Outcome of Board Meeting held on 12th May 2021. You are requested to take on record following inadvertent errors/ corrections required in Annexure 1 to above referred letter: 1. The name of the entity mentioned at Sr. no. 8 should be read as 'Cohesion MK Best Ideas Sub-Trust' instead of 'Cohesion Investment (Cayman) Limited'. 2. The name of the entities mentioned at Sr. no. 25 and 26 needs to be inter-changed i.e. Sr. No. 25 should be read as 'The TIFF Keystone Fund, L.P' instead of 'Catholic Endowment Fund, L.P..' and Sr. No. 26 should be read as 'Catholic Endowment Fund, L.P.. instead of 'The TIFF Keystone Fund, L.P'
14-05-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we enclose herewith the Press Release on the above mentioned subject being released by the Company, which is self-explanatory. We request you to kindly take the same on record.
14-05-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Preferential Issue

 Outcome of Board Meeting pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
12-05-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Outcome Of Board Meeting

 Kindly refer to attached letter
12-05-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Clarification - Movement In Price

 We confirm that the Company is in compliance with the requirements of Regulation 30 of the SEBI (LODR) Regulations, 2015 and that we are not aware of any undisclosed information, which in our opinion may have a bearing on the price / volume behaviour in our scrip. In this connection, we bring to your notice our letter no. SPARC/Sec/SE/2021-22/010 dated 9th May 2021, whereby we had informed you that a meeting of the Board of Directors of the Company will be held on Wednesday, 12th May, 2021, inter alia, to consider and evaluate proposals for raising of funds in one or more tranches by way of issue of Equity Shares or Securities/ Warrants convertible into Equity shares of the Company, through permissible modes including by way of Preferential Issue, subject to the receipt of necessary approvals. We remain committed to make adequate and timely disclosure of any material or price sensitive information to the Stock Exchanges in compliance with the applicable regulations.
12-05-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Clarification sought from Sun Pharma Advanced Research Company Ltd

 The Exchange has sought clarification from Sun Pharma Advanced Research Company Ltd on May 12, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
12-05-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Board Meeting Intimation for Notice Of Board Meeting For Consideration Of Audited Results Of The Company For The Quarter And Financial Year Ended 31St March 2021

 SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2021 ,inter alia, to consider and approve Pursuant to regulation 29 (1) of the SEBI (Listing obligation & Disclosure Requirements) Regulation, 2015, we hereby inform you that a meeting of the Board of Directors of Sun Pharma Advanced Research Company Limited will be held on Monday, 17th May 2021, inter alia, to consider and approve, the audited financial results of the Company for the quarter and financial year ended 31st March 2021. Further, kindly note that pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the trading window for trading by designated persons, shall remain closed upto 48 hours after the declaration of financial results of the Company on 17th May 2021.
09-05-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Board Meeting Intimation for Notice Of Board Meeting To Consider Fund Raising

 SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2021 ,inter alia, to consider and approve Pursuant to regulation 29 (1) (d) of the SEBI (LODR) Regulation, 2015, we hereby inform you that a meeting of the Board of Directors of Sun Pharma Advanced Research Company Limited will be held on Wednesday, 12th May 2021, inter alia, to consider and evaluate proposals for raising of funds in one or more tranches by way of issue of Equity Shares or Securities/ Warrants convertible into Equity shares of the Company, through permissible modes including by way of Preferential Issue, subject to the receipt of necessary approvals.
09-05-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Sun Pharma Advanced Research Company Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
28-04-2021
Next Page
Close

Let's Open Free Demat Account